{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:17:05Z","timestamp":1771597025506,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12580-8","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T02:24:14Z","timestamp":1769567054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 burden in the paediatric population in Latin America during vaccine rollout: a real-world study using national surveillance data"],"prefix":"10.1186","volume":"26","author":[{"given":"J\u00falia","family":"Spinardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Silva-Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"D\u00edaz-Puentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nohemi","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Buitrago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius","family":"Goularte-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe H.","family":"Kyaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A. P.","family":"Safadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"12580_CR1","unstructured":"Castillo C, Marinho ML. The impacts of the pandemic on the health and well-being of children. Latin America and the Caribbean and its effect on child-sensitive social protection systems. Economic Commission for Latin America and the Caribbean (ECLAC); 2022."},{"key":"12580_CR2","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.jped.2022.11.006","volume":"99","author":"F Da Lima","year":"2023","unstructured":"Da Lima F, Leite EJ. COVID-19 vaccination in children: a public health priority. Jornal De Pediatria. 2023;99:S28\u201336.","journal-title":"Jornal De Pediatria"},{"key":"12580_CR3","doi-asserted-by":"crossref","unstructured":"Kulkarni D, Ismail NF, Zhu F, Wang X, Del Carmen Morales G, Srivastava A, et al. Epidemiology and clinical features of SARS-CoV-2 infection in children and adolescents in the pre-Omicron era: A global systematic review and meta-analysis. J Global Health. 2024;14.","DOI":"10.7189\/jogh.14.05003"},{"issue":"2","key":"12580_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41390-023-02549-7","volume":"94","author":"GA Rotulo","year":"2023","unstructured":"Rotulo GA, Palma P. Understanding COVID-19 in children: immune determinants and post-infection conditions. Pediatr Res. 2023;94(2):434\u201342.","journal-title":"Pediatr Res"},{"issue":"1","key":"12580_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12941-022-00505-7","volume":"21","author":"AJ Rodriguez-Morales","year":"2022","unstructured":"Rodriguez-Morales AJ, Leon-Figueroa DA, Romani L, McHugh TD, Leblebicioglu H. Vaccination of children against COVID-19: the experience in Latin America. Ann Clin Microbiol Antimicrob. 2022;21(1):14.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"5","key":"12580_CR6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s40121-023-00804-2","volume":"12","author":"J Spinardi","year":"2023","unstructured":"Spinardi J, Dantas AC, Carballo C, Thakkar K, Akoury NA, Kyaw MH, et al. Narrative review of the evolution of COVID-19 vaccination recommendations in countries in Latin America, Africa and the middle East, and Asia. Infect Dis Therapy. 2023;12(5):1237\u201364.","journal-title":"Infect Dis Therapy"},{"key":"12580_CR7","doi-asserted-by":"crossref","unstructured":"Jayaraj VJ, Husin M, Suah JL, Tok PSK, Omar A, Rampal S, et al. Effectiveness of COVID-19 vaccines among children 6\u201311 years against hospitalization during Omicron predominance in Malaysia. Sci Rep. 2024;14(1).","DOI":"10.1038\/s41598-024-55899-5"},{"issue":"12","key":"12580_CR8","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1007\/s00431-023-05216-5","volume":"182","author":"Z Lan","year":"2023","unstructured":"Lan Z, Yan J, Yang Y, Tang Z, Guo X, Wu Z, et al. Effectiveness of COVID-19 vaccines among children and adolescents against SARS-CoV-2 variants: a meta-analysis. Eur J Pediatrics. 2023;182(12):5235\u201344.","journal-title":"Eur J Pediatrics"},{"issue":"6","key":"12580_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S2352-4642(23)00078-0","volume":"7","author":"V Piechotta","year":"2023","unstructured":"Piechotta V, Siemens W, Thielemann I, Toews M, Koch J, Vygen-Bonnet S, et al. Safety and effectiveness of vaccines against COVID-19 in children aged 5\u201311 years: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2023;7(6):379\u201391.","journal-title":"Lancet Child Adolesc Health"},{"key":"12580_CR10","doi-asserted-by":"crossref","unstructured":"Fernandes Nehab M, Gon\u00e7alves Camacho K, Teixeira Reis A, Junqueira-Marinho MDF, Marques Abramov D, Almeida, De Azevedo ZM, et al. Willingness of Brazilian caregivers in having their children and adolescents vaccinated against Covid-19. Vaccine. 2023;41(3):735\u2009\u2013\u200943.","DOI":"10.1016\/j.vaccine.2022.11.077"},{"issue":"33","key":"12580_CR11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.15585\/mmwr.mm7233a2","volume":"72","author":"R Link-Gelles","year":"2023","unstructured":"Link-Gelles R, Ciesla AA, Rowley EAK, Klein NP, Naleway AL, Payne AB, et al. Effectiveness of monovalent and bivalent mRNA vaccines in preventing COVID-19\u2013Associated emergency department and urgent care encounters among children aged 6 Months\u20135 Years \u2014 VISION Network, united States, July 2022\u2013June 2023. MMWR Morbidity Mortal Wkly Rep. 2023;72(33):886\u201392.","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"issue":"9","key":"12580_CR12","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.vaccine.2024.02.067","volume":"42","author":"WHS Wong","year":"2024","unstructured":"Wong WHS, Leung DL, Yip KM, So HK, Rosa Duque JS, Lau YL. Effectiveness of inactivated COVID-19 vaccine coronavac in children aged less than 3 years old during Omicron wave in Hong Kong. Vaccine. 2024;42(9):2135\u20137.","journal-title":"Vaccine"},{"key":"12580_CR13","doi-asserted-by":"crossref","unstructured":"Zeng B, Gao L, Zhou Q, Yu K, Sun F. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med. 2022;20(1).","DOI":"10.1186\/s12916-022-02397-y"},{"key":"12580_CR14","unstructured":"Hodcroft EB, CoVariants. SARS-CoV-2 Mutations and Variants of Interest. 2021."},{"key":"12580_CR15","unstructured":"Argentina MdS. Argentina comienza la vacunaci\u00f3n de los adolescentes de 12 a 17 a\u00f1os con condiciones priorizadas: se distribuyen m\u00e1s de 900 mil dosis de Moderna en todo el pa\u00ed 2021 [Available from: https:\/\/www.argentina.gob.ar\/noticias\/argentina-comienza-la-vacunacion-de-los-adolescentes-de-12-17-anos-con-condiciones"},{"key":"12580_CR16","unstructured":"Colombia MdSyPS. Lleg\u00f3 el turno de vacunar a menores entre los 12 y 14 a\u00f1os 2021 [Available from: https:\/\/www.minsalud.gov.co\/Paginas\/Llego-el-turno-de-vacunar-a-menores-entre-los-12-y-14-anos-.aspx"},{"key":"12580_CR17","doi-asserted-by":"crossref","unstructured":"Bautista LE, Rodr\u00edguez-Villamizar LA, Herrera-Galindo VM, Mart\u00ednez-Vega RA, Sosa-\u00c1vila LM, Or\u00f3stegui-Arenas M, et al. \u00bfEs prioritario vacunar a ni\u00f1os de 3\u201311 a\u00f1os contra COVID-19 En colombia? Salud UIS. 2021;53(1).","DOI":"10.18273\/saluduis.53.e:21038"},{"key":"12580_CR18","unstructured":"Ballarino F. Coronavirus: qu\u00e9 sabemos sobre la vacuna Sinopharm en los ni\u00f1os. Chequeando. 2021."},{"key":"12580_CR19","unstructured":"Simoes E, Brazil approves Pfizer. COVID-19 vaccine for children over 12 [Available from: https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/brazil-approves-pfizer-covid-19-vaccine-children-over-12-2021-06-11\/"},{"key":"12580_CR20","unstructured":"Reuters. Brazil approves Pfizer vaccine for children as young as six months Reuters2022 [Available from: https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/brazil-approves-pfizer-vaccine-children-young-six-months-2022-09-17\/"},{"key":"12580_CR21","unstructured":"Brandao M. Sa\u00fade recomenda vacina\u00e7\u00e3o de crian\u00e7as de 3 a 5 anos com CoronaVac Agencia Brasil2022 [Available from: https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2022-07\/saude-recomenda-vacinacao-de-criancas-de-3-5-anos-com-coronavac"},{"key":"12580_CR22","unstructured":"Mexico Sds. Vacunaci\u00f3n contra COVID-19 para ni\u00f1as y ni\u00f1os de 5 a 11 a\u00f1os [Available from: https:\/\/vacunacovid.gob.mx\/vacunacion-contra-covid-19-para-ninas-y-ninos-de-5-a-11-anos\/#:~:text=%C2%BFCu%C3%A1l%20vacuna%20se%20les%20aplicar%C3%A1,principios%20de%20marzo%20de%202022"},{"key":"12580_CR23","doi-asserted-by":"crossref","unstructured":"Diaz M, Silva G, Spinardi J, Buitrago D, Garc\u00eda IC, Kyaw MH. Severe COVID-19 Outcomes in Five Latin American Countries in the Postvaccination Era. 2024.","DOI":"10.2139\/ssrn.4700105"},{"key":"12580_CR24","unstructured":"Argentina MdSd. COVID-19. Casos registrados en la Rep\u00fablica Argentina http:\/\/datos.salud.gob.ar\/dataset\/covid-19-casos-registrados-en-la-republica-argentina2022 [updated 2023."},{"key":"12580_CR25","unstructured":"Argentina MdS, ESTRATEGIA INTEGRADA DE VIGILANCIA DE LAS. INFECCIONES RESPIRATORIAS AGUDAS DE POSIBLE ORIGEN VIRAL."},{"key":"12580_CR26","unstructured":"Ministerio de Salud Argentina. ANEXO I. GU\u00cdA PARA LA VIGILANCIA EPIDEMIOL\u00d3GICA DE COVID-19. 2020."},{"key":"12580_CR27","unstructured":"Health BMo. openDataSUS2022. Available from: https:\/\/opendatasus.saude.gov.br\/"},{"key":"12580_CR28","unstructured":"Social MdSyP. Que es SISPRO2023. Available from: https:\/\/www.sispro.gov.co\/Pages\/Home.aspx"},{"key":"12580_CR29","unstructured":"Informaci\u00f3n del Sistema de Vigilancia Epidemiol\u00f3gica de Enfermedades Respiratoria Viral [Database on Internet]. 2020 Apr 14. Mexico City. Secretar\u00eda de Salud, Mexico. Available from: https:\/\/www.datos.gob.mx\/busca\/dataset\/informacion-referente-a-casos-covid-19-en-mexico"},{"key":"12580_CR30","unstructured":"Amsterdam CvWeI. Python Reference Manual 3.8.10 ed."},{"issue":"9596","key":"12580_CR31","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"key":"12580_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/CLEP.S110528","volume":"8","author":"S Nicholls","year":"2016","unstructured":"Nicholls S, Langan S, S\u00f8rensen HT, Petersen I, Benchimol E. The RECORD reporting guidelines: meeting the methodological and ethical demands of transparency in research using routinely-collected health data. Clin Epidemiol. 2016;8:389\u201392.","journal-title":"Clin Epidemiol"},{"key":"12580_CR33","doi-asserted-by":"crossref","unstructured":"Sousa BLA, Silva CA, Ferraro AA. An update on the epidemiology of pediatric COVID-19 in Brazil. Revista Paulista De Pediatria. 2022;40.","DOI":"10.1590\/1984-0462\/2022\/40\/2021367"},{"key":"12580_CR34","unstructured":"National Center for Immunization and Respiratory Diseases (NCIRD) DoVD. COVID-NET Interactive Dashboard 2024 [Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covidnetdashboard\/de\/powerbi\/dashboard.html"},{"key":"12580_CR35","doi-asserted-by":"crossref","unstructured":"Marks KJWM, Agathis NT. Hospitalization of infants and children aged 0\u20134 years with laboratoryconfirmed COVID-19 \u2014 COVID-NET, 14 States, March 2020\u2013February 2022. MMWR and Morbidity and Mortality Weekly Repor; 2022.","DOI":"10.15585\/mmwr.mm7111e2"},{"key":"12580_CR36","doi-asserted-by":"publisher","first-page":"1060311","DOI":"10.3389\/fped.2023.1060311","volume":"11","author":"E Ortiz-Prado","year":"2023","unstructured":"Ortiz-Prado E, Izquierdo-Condoy JS, Fernandez-Naranjo R, Vasconez J, Davila Rosero MG, Revelo-Bastidas D, et al. The deadly impact of COVID-19 among children from Latin america: the case of Ecuador. Front Pediatr. 2023;11:1060311.","journal-title":"Front Pediatr"},{"issue":"1","key":"12580_CR37","doi-asserted-by":"publisher","first-page":"e2253590","DOI":"10.1001\/jamanetworkopen.2022.53590","volume":"6","author":"S Flaxman","year":"2023","unstructured":"Flaxman S, Whittaker C, Semenova E, Rashid T, Parks RM, Blenkinsop A, et al. Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US. JAMA Netw Open. 2023;6(1):e2253590.","journal-title":"JAMA Netw Open"},{"key":"12580_CR38","doi-asserted-by":"crossref","unstructured":"Poukka E, Andersson NW, Thiesson EM, Baum U, Pihlstr\u00f6m N, Per\u00e4l\u00e4 J, et al. COVID-19 vaccine effectiveness among adolescents. Pediatrics. 2024;153(2).","DOI":"10.1542\/peds.2023-062520"},{"key":"12580_CR39","doi-asserted-by":"publisher","first-page":"100487","DOI":"10.1016\/j.lana.2023.100487","volume":"21","author":"A Jara","year":"2023","unstructured":"Jara A, Undurraga EA, Flores JC, Zubizarreta JR, Gonz\u00e1lez C, Pizarro A, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study. Lancet Reg Health - Americas. 2023;21:100487.","journal-title":"Lancet Reg Health - Americas"},{"issue":"4","key":"12580_CR40","doi-asserted-by":"publisher","first-page":"e247822","DOI":"10.1001\/jamanetworkopen.2024.7822","volume":"7","author":"JR Head","year":"2024","unstructured":"Head JR, Collender PA, Leon TM, White LA, Sud SR, Camponuri SK, et al. COVID-19 vaccination and incidence of pediatric SARS-CoV-2 infection and hospitalization. JAMA Netw Open. 2024;7(4):e247822.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"12580_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","volume":"28","author":"T Fiolet","year":"2022","unstructured":"Fiolet T, Kherabi Y, Macdonald C-J, Ghosn J, Peiffer-Smadja N, Comparing. COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202\u201321.","journal-title":"Clin Microbiol Infect"},{"key":"12580_CR42","doi-asserted-by":"crossref","unstructured":"Hogan AB, Doohan P, Wu SL, Mesa DO, Toor J, Watson OJ, et al. Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach. Nat Commun. 2023;14(1).","DOI":"10.1038\/s41467-023-39736-3"},{"issue":"45","key":"12580_CR43","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.15585\/mmwr.mm7145a2","volume":"71","author":"HG Rosenblum","year":"2022","unstructured":"Rosenblum HG, Wallace M, Godfrey M, Roper LE, Hall E, Fleming-Dutra KE, et al. Interim recommendations from the advisory committee on immunization practices for the use of bivalent booster doses of COVID-19 Vaccines \u2014 United States, October 2022. MMWR Morbidity Mortal Wkly Rep. 2022;71(45):1436\u201341.","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"key":"12580_CR44","doi-asserted-by":"publisher","first-page":"e15492","DOI":"10.7717\/peerj.15492","volume":"11","author":"M Martella","year":"2023","unstructured":"Martella M, Peano A, Politano G, Onorati R, Gianino MM. Paediatric hospitalizations over three waves of COVID-19 (February 2020 to May 2021) in italy: determinants and rates. PeerJ. 2023;11:e15492.","journal-title":"PeerJ"},{"issue":"7","key":"12580_CR45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa2211031","volume":"388","author":"FM Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz FM, Sher LD, Sabharwal C, Gurtman A, Xu X, Kitchin N, et al. Evaluation of BNT162b2 Covid-19 vaccine in children younger than 5 years of age. N Engl J Med. 2023;388(7):621\u201334.","journal-title":"N Engl J Med"},{"issue":"10","key":"12580_CR46","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/vaccines9101115","volume":"9","author":"LE Bagateli","year":"2021","unstructured":"Bagateli LE, Saeki EY, Fadda M, Agostoni C, Marchisio P, Milani GP. COVID-19 vaccine hesitancy among parents of children and adolescents living in Brazil. Vaccines. 2021;9(10):1115.","journal-title":"Vaccines"},{"issue":"2","key":"12580_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.vaccine.2023.11.064","volume":"42","author":"W Gramacho","year":"2024","unstructured":"Gramacho W, Turgeon M, Santos Mundim P, Pereira I. Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants. Vaccine. 2024;42(2):315\u201321.","journal-title":"Vaccine"},{"key":"12580_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.puhe.2022.10.024","volume":"214","author":"VS Santos","year":"2023","unstructured":"Santos VS, Siqueira TS, Silva JRS, Gurgel RQ. Spatial clustering of low rates of COVID-19 vaccination among children and adolescents and their relationship with social determinants of health in brazil: a nationwide population-based ecological study. Public Health. 2023;214:38\u201341.","journal-title":"Public Health"},{"issue":"49","key":"12580_CR49","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1016\/j.vaccine.2021.10.077","volume":"39","author":"B McKinnon","year":"2021","unstructured":"McKinnon B, Quach C, Dub\u00e9 \u00c8, Tuong Nguyen C, Zinszer K. Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada. Vaccine. 2021;39(49):7140\u20135.","journal-title":"Vaccine"},{"issue":"2","key":"12580_CR50","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.vaccine.2022.11.067","volume":"41","author":"A Al-Kassab-C\u00f3rdova","year":"2023","unstructured":"Al-Kassab-C\u00f3rdova A, Silva-Perez C, Mendez-Guerra C, Sangster-Carrasco L, Arroyave I, Cabieses B, et al. Inequalities in infant vaccination coverage during the COVID-19 pandemic: A population-based study in Peru. Vaccine. 2023;41(2):564\u201372.","journal-title":"Vaccine"},{"key":"12580_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijregi.2022.12.003","volume":"7","author":"D Jarovsky","year":"2023","unstructured":"Jarovsky D, de Freitas Fongaro G, Zampol RM, de Oliveira TA, Farias CGA, da Silva D, et al. Characteristics and clinical outcomes of COVID-19 in children: a hospital-based surveillance study in Latin america\u2019s hardest-hit City. IJID Reg. 2023;7:52\u201362.","journal-title":"IJID Reg"},{"key":"12580_CR52","doi-asserted-by":"crossref","unstructured":"Hart JD, Ong DS, Chokephaibulkit K, Ong-Lim AT, Vereti I, Crawford NW, et al. Considerations for vaccinating children against COVID-19. BMJ Paediatr Open. 2023;7(1).","DOI":"10.1136\/bmjpo-2023-001964"},{"issue":"4","key":"12580_CR53","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1097\/INF.0000000000003043","volume":"40","author":"K Graff","year":"2021","unstructured":"Graff K, Smith C, Silveira L, Jung S, Curran-Hays S, Jarjour J, et al. Risk factors for severe COVID-19 in children. Pediatr Infect Disease J. 2021;40(4):e137\u201345.","journal-title":"Pediatr Infect Disease J"},{"key":"12580_CR54","doi-asserted-by":"crossref","unstructured":"Aparicio C, Willis ZI, Nakamura MM, Wolf J, Little C, Maron GM, et al. Risk factors for pediatric critical COVID-19: a systematic review and meta-analysis. 2024.","DOI":"10.1101\/2024.01.17.24301452"},{"key":"12580_CR55","doi-asserted-by":"crossref","unstructured":"Sol\u00f3rzano-Santos F, Miranda-Lora AL, M\u00e1rquez-Gonz\u00e1lez H, Kl\u00fcnder-Kl\u00fcnder M. Survival analysis and mortality predictors of COVID-19 in a pediatric cohort in Mexico. Front Public Health. 2022;10.","DOI":"10.3389\/fpubh.2022.969251"},{"issue":"5","key":"12580_CR56","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/S2352-4642(21)00066-3","volume":"5","author":"SS Bhopal","year":"2021","unstructured":"Bhopal SS, Bagaria J, Olabi B, Bhopal R. Children and young people remain at low risk of COVID-19 mortality. Lancet Child Adolesc Health. 2021;5(5):e12\u20133.","journal-title":"Lancet Child Adolesc Health"},{"key":"12580_CR57","doi-asserted-by":"crossref","unstructured":"Sumner MW, Kanngiesser A, Lotfali-Khani K, Lodha N, Lorenzetti D, Funk AL, et al. Severe outcomes associated with SARS-CoV-2 infection in children: A systematic review and Meta-Analysis. Front Pead. 2022;10.","DOI":"10.3389\/fped.2022.916655"},{"key":"12580_CR58","doi-asserted-by":"crossref","unstructured":"Bardach A, Ruvinsky S, Moreno C, Perelli L, Kyaw MH, Spinardi J, et al. Pediatric COVID-19 in argentina: a comprehensive analysis of disease and economic burden through official data and a systematic literature review. Front Pead. 2024;12.","DOI":"10.3389\/fped.2024.1352260"},{"key":"12580_CR59","doi-asserted-by":"publisher","first-page":"101287","DOI":"10.1016\/j.eclinm.2022.101287","volume":"44","author":"R Harwood","year":"2022","unstructured":"Harwood R, Yan H, Talawila Da Camara N, Smith C, Ward J, Tudur-Smith C, et al. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis. eClinicalMedicine. 2022;44:101287.","journal-title":"eClinicalMedicine"},{"issue":"5","key":"12580_CR60","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41390-021-01402-z","volume":"90","author":"DM Cooper","year":"2021","unstructured":"Cooper DM, Afghani B, Byington CL, Cunningham CK, Golub S, Lu KD, et al. SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges. Pediatr Res. 2021;90(5):966\u201370.","journal-title":"Pediatr Res"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12580-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12580-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12580-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:45:15Z","timestamp":1771595115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12580-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12580"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12580-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Drafting support for the preparation of this manuscript was provided by IQVIA and was funded by Pfizer. The authors do not report other relevant affiliations or financial involvement with any organisation or entity with an interest or conflict with the subject matter or materials discussed in the manuscript in addition to those disclosed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"422"}}